In addition to the HS status, we also tested HF likely according to the age-adjusted NT-proBNP cut-points proposed by the 2023 Clinical Consensus of the HFA of the ESC for outpatients suspected of de novo HF. The gene discussed is NPPB; the disease is hydrops fetalis.